PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
28-Oct-2021 Meissa Announces Positive Preliminary Clinical Data on Safety and Immunogenicity of Intranasal COVID-19 Vaccine Businesswire
28-Oct-2021 TriMas Reports Third Quarter 2021 Results Businesswire
28-Oct-2021 Real Chemistry’s Global President, Jennifer Gottlieb, Appointed to the Ad Council’s Board of Directors Businesswire
28-Oct-2021 Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity Businesswire
28-Oct-2021 Avoro Capital Issues Open Letter to Fellow Acceleron Pharma Shareholders Businesswire
28-Oct-2021 Triumvira Appoints Oncology Industry Veteran Deyaa Adib, M.D., as Chief Medical Officer Businesswire
28-Oct-2021 Alnylam Announces Planned CEO Leadership Transition Businesswire
28-Oct-2021 Vita 34 AG: Exchange Offer PBKM - 95% Minimum Acceptance Rate Exceeded Vita 34 AG
28-Oct-2021 $225+ Billion Healthcare Logistics Market - Global Outlook & Forecast 2021-2026 - ResearchAndMarkets.com Businesswire
28-Oct-2021 Aerie Pharmaceuticals to Announce Third Quarter 2021 Financial Results and Host Conference Call on Thursday, November 4, 2021 Businesswire
28-Oct-2021 BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto Businesswire
28-Oct-2021 Baxter Reports Third-Quarter 2021 Results Businesswire
28-Oct-2021 $5.66 Billion Vaccine Storage and Packaging Market - Global Outlook & Forecast 2021-2026 - ResearchAndMarkets.com Businesswire
28-Oct-2021 Global Oleochemicals Markets Outlook & Forecast Report 2021: Market is Expected to Reach $38.57 Billion by 2026, Growing at a CAGR of 5.74% - ResearchAndMarkets.com Businesswire
28-Oct-2021 Aldeyra Therapeutics Reports Third-Quarter 2021 Financial Results and Recent Corporate Highlights Businesswire
28-Oct-2021 Can-Fite’s NASH Patents Granted and Allowed in Japan, Hong Kong, and Mexico Businesswire
28-Oct-2021 Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program Businesswire
28-Oct-2021 Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year Businesswire
28-Oct-2021 An Inhaled Therapeutic Developed At Texas A&M Has Been Shown To Be Effective Against Most Known Respiratory Infections, Including COVID-19 Businesswire
28-Oct-2021 Exicure to Present at Upcoming Scientific Conferences Businesswire